Arch Pharmalabs Ltd

Arch Pharmalabs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Arch Pharmalabs Ltd

₹ None%
- close price
Company website
About
[ add key points ]
Website
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE -5.01 %
  • ROE -46.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -8.18% over past five years.
  • Company has a low return on equity of -21.5% over last 3 years.
  • Company has high debtors of 938 days.
  • Working capital days have increased from 744 days to 1,644 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
247 363 514 713 1,023 1,278 1,494 1,881 466
201 300 419 577 781 954 1,084 1,671 554
Operating Profit 46 63 95 136 242 324 410 210 -88
OPM % 19% 17% 18% 19% 24% 25% 27% 11% -19%
1 14 3 2 6 9 25 14 2
Interest 15 25 36 60 131 154 223 288 306
Depreciation 8 12 16 24 46 60 73 86 94
Profit before tax 23 40 47 55 71 118 138 -149 -486
Tax % 31% 24% 28% 33% 29% 29% 27% 8% 0%
16 30 33 37 51 83 101 -161 -488
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: -8%
3 Years: -29%
TTM: -75%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -202%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: -12%
3 Years: -22%
Last Year: -47%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
Equity Capital 14 16 21 21 21 25 25 28 28
Reserves 69 155 328 365 446 653 754 740 1,289
187 297 385 855 1,126 1,251 1,497 2,191 2,934
59 73 92 241 291 402 540 692 338
Total Liabilities 328 541 826 1,482 1,884 2,331 2,816 3,651 4,588
126 183 260 461 577 649 739 804 1,683
CWIP 23 9 11 117 67 30 49 31 29
Investments 1 13 79 72 49 49 49 50 50
180 337 476 832 1,191 1,602 1,978 2,766 2,827
Total Assets 328 541 826 1,482 1,884 2,331 2,816 3,651 4,588

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
-6 -41 12 -140 -75 145 130 -376
-55 -61 -162 -318 -72 -219 -130 -142
63 144 197 404 157 84 6 557
Net Cash Flow 2 42 46 -55 9 10 5 39

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
Debtor Days 121 119 111 159 170 153 145 183 938
Inventory Days 166 183 157 240 211 214 239 249 766
Days Payable 105 88 74 159 123 151 172 150 240
Cash Conversion Cycle 183 214 194 241 258 216 212 282 1,464
Working Capital Days 175 228 218 297 318 286 264 325 1,644
ROCE % 16% 14% 12% 14% 15% 17% 5% -5%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

No data available.

Credit ratings